SARS-CoV-2 rapid diagnostic tests for emerging variants
- PMID: 34223400
- PMCID: PMC8241290
- DOI: 10.1016/S2666-5247(21)00147-6
SARS-CoV-2 rapid diagnostic tests for emerging variants
Conflict of interest statement
This work was supported by the Swiss National Science Foundation (grant number 196383), the Fondation Ancrage Bienfaisance du Groupe Pictet, and the Foundation for Innovative New Diagnostics (FIND). The Swiss National Science Foundation and the Fondation Ancrage Bienfaisance du Groupe Pictet had no role in data collection, analysis, or interpretation. Antigen-detecting rapid diagnostic tests were provided by FIND and FIND was involved in methodology, data analysis, interpretation and writing. JAE and CE are employees of FIND. We declare no competing interests.
References
-
- WHO Weekly epidemiological update on COVID-19. May, 11 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on...
-
- Public Health England Guidance SARS-CoV-2 lateral flow antigen tests: evaluation of VUI-202012/01. Dec 23, 2020. https://www.gov.uk/government/publications/sars-cov-2-lateral-flow-antig...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous